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Purpose: The purpose of this study was to validate the role of the total malignancy score (TMS) 
in identifying thyroid nodules suspicious for malignancy through the sum of their ultrasound 
features. 
Methods: The local ethical committee approved this prospective observational study. We 
examined 231 nodules in 231 consecutive patients (164 females and 67 males; age range, 20 to 
87 years; median age, 59 years; interquartile range, 48 to 70 years) who underwent ultrasound 
followed by fine-needle aspiration cytology (FNAC). The nodules were further classified using 
the TMS, which considers ultrasound features (number, echogenicity, structure, halo, margins, 
Doppler signal, calcifications, and growth), and the Bethesda System for Reporting Thyroid 
Cytopathology (TBSRTC), which considers cytological features. Patients with non-negative 
nodules (TBSRTC categories III to VI) underwent histological analysis, repeated FNAC, or 2 
years of regular ultrasound follow-up. The associations between the final diagnosis, each of the 
ultrasound features, and the TMS were estimated using the chi-square test, the Mann-Whitney 
U test, and multivariate logistic regression. A receiver operating characteristic (ROC) curve was 
used to evaluate the diagnostic accuracy of the TMS.
Results: On ultrasound, 47% of the nodules (108 of 231) had a TMS <3, 18% (42 of 231) had 
a TMS of 3, and 35% (81 of 231) had a TMS >3. The FNAC results of 85% of the nodules (196 
of 231) were benign, while 15% (35 of 231) had non-negative results. Hypoechogenicity, solid 
structure, the presence of microcalcifications, and the number of nodules were independent 
predictors of the final diagnosis, and the diagnostic accuracy of the TMS was good (area under 
the ROC curve, 0.82). 
Conclusion: The TMS system is simple to use, reliable, easily reproducible, and closely reflects 
malignancy risk. Based on our results, FNAC could be limited to nodules with a TMS ≥3 without 
missing any cases of carcinoma.
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Introduction
Thyroid nodules are very common findings in the adult population, 
especially in women [1]. The prevalence on clinical examinations 
is about 4%-7%, but the widespread use of ultrasound (US) has 
increased it to as high as 67% [2-5]. The discovery of non-palpable 
nodules raises concerns about their possible malignancy. Most of 
the detected nodules are benign, while 3%-7% are malignant [6-
8], mainly affecting patients younger than 20 years or older than 
60 years [4,9]. Moreover, given the financial burden on the health 
system and the unnecessary anxiety it induces in patients, it is 
unrealistic to biopsy every thyroid nodule to confirm the diagnosis 
[10]. In addition, thyroid cancer has an excellent prognosis and long-
term survival rate, and aggressive early interventions may not affect 
the clinical outcomes, as is the case for other kinds of cancer [11]. 
Therefore, the challenge is to correctly identify malignant nodules 
and to avoid unnecessary procedures for benign ones. Suspicious 
US features may be useful for selecting patients for fine-needle 
aspiration cytology (FNAC) when incidental nodules are discovered 
and when multiple nodules are present.
No single accepted guideline exists for the management of 
thyroid nodules. FNAC is considered the method of choice to 
diagnose thyroid cancer, but it is an invasive procedure [12]. Thus, it 
can be avoided in nodules without suspicious characteristics in favor 
of a less invasive test. Many studies have attempted to identify US 
features pathognomonic for malignancy, leading to a system of risk 
stratification based on the following predictors: solid or mostly solid 
structure, hypoechogenicity, irregular margins, microcalcifications, a 
discontinuous halo, taller-than-wide (TTW) shape, intralesional flow 
on Doppler examinations, and a >20% size increase in 6 months 
[5,7-14]. 
In a previous study of thyroid follicular proliferation, the US-based 
total malignancy score (TMS) was proposed for risk stratification, 
and it was suggested that US follow-up may be appropriate for 
nodules with a TMS <3 (low malignant potential) (Table 1) [15]. 
This score has the potential to simplify the practical management of 
thyroid nodules.
The aim of this study was to validate the role of the TMS in 
identifying thyroid nodules suspicious for malignancy through the 
sum of their US features and to estimate its usefulness in a large 
population. We evaluated the predictive value of US findings in the 
diagnosis of malignant thyroid nodules and attempted to identify 
features that might be useful for making practical decisions about 
the management of malignant thyroid nodules.
Materials and Methods
Patients
The Intercompany Ethics Committee of Zone A, Milan approved this 
prospective observational study. All patients enrolled in this study 
provided written informed consent before each invasive procedure. 
Informed consent was not required for the diagnostic ultrasound. 
All patients who underwent FNAC of a suspicious thyroid 
nodule between September 2012 and April 2015 were analyzed. 
US was performed immediately before the FNAC procedure. For 
each patient, the TMS of the suspicious nodule was calculated, as 
previously described (Table 1) [15]. A cytological report classifying 
each nodule according to the six general diagnostic categories of the 
Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) was 
produced [16]. Nodules reported as inadequate (TBSRTC category I) 
were excluded from the study. Nodules classified as category II were 
considered definitively negative and the patients did not undergo 
further examinations. Nodules classified as category III, IV, V, or VI 
were considered non-negative, and those patients were managed 
through histologic analysis, repeated FNAC, or ≥2 years of regular 
US follow-up.




Number Many - Single
Margins Regular - Irregular
Color flow Perinodular Peri-intranodular Intranodular
Structure Colloidal Solid -
Echogenicity Anechoic, isoechoic, or hyperechoic Hypoechoic -
Halo Continuous Discontinuous -
Calcifications Macrocalcifications Microcalcifications -
Growth - >20% in 6 months -
Adapted from Pompili et al. Ultrasound Med Biol 2013;39:1350-1355, with permission of Elsevier [15].
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Image Analysis
US examinations were performed by three board-certified 
radiologists (G.G.P., S.T., and N.F.) with more than 10 years of 
experience in neck imaging, using a General Electric Logiq 9 US 
system (GE Healthcare, Milwaukee, WI, USA) with a linear 9-14 
MHz frequency probe. A pulse repetition frequency of 2400 Hz and 
a color gain of 40%-50% were used for Doppler US, performed 
with a linear high-frequency probe (7.5-10 MHz). The radiologist 
who performed the diagnostic US also performed US-guided FNAC 
of the suspicious nodules. A cytopathologist was on site during 
the FNAC procedures and a quick assessment was made of the 
sample adequacy (i.e., the presence in the sample of enough thyroid 
cells to reach a diagnosis) by means of an ultrafast Papanicolaou 
stain. Aspiration was performed with 10-cm-long 23G or 25G 
needles, first by capillarity and, eventually, by forced syringe suction. 
Papanicolaou staining and hematoxylin and eosin staining were the 
most commonly used stains for diagnosis. 
According to the cytopathologist’s requirements, 1-4 aspirations 
were performed on nodules with suspicious US features. For each 
nodule, the individual US features were summed up to obtain the 
TMS; the cytopathologist was blinded to the TMS score results. 
Based on incoming evidence, when the study was already in 
progress, we also decided to evaluate whether lesions had a TTW 
shape. Unfortunately, as in our hospital US images are not available 
on the picture archiving and communication system, we were only 
able to consider this feature for slightly less than half of the nodules, 
and it was not included in the score of any nodules.
Statistical Analysis
The relationships between each US feature, the TMS, the nodule size 
(maximum diameter), the patient’s age, and the final diagnosis were 
estimated.
Continuous variables were expressed as median and interquartile 
range (IQR), whereas categorical variables were expressed as counts 
and percentages. Associations between the final diagnosis and 
each of the US features were estimated using the chi-square test, 
whereas associations of the diagnosis with the nodule’s diameter 
and the patient’s age were estimated using the Mann-Whitney U 
test. Multivariate logistic regression was performed using variables 
found to be statistically significant in the bivariate analysis as 
predictors of the final diagnosis. A receiver operating characteristic 
(ROC) curve was obtained for the diagnostic accuracy of TMS.
All analyses were performed using SPSS ver. 17 software (SPSS 
Inc., Chicago, IL, USA), and P-values <0.05 were considered to 
indicate statistical significance.
Results
US-guided FNAC was performed in 249 thyroid nodules in 249 
patients. The FNAC results for 18 nodules were excluded due to 
non-diagnostic or unsatisfactory samples (TBSRTC category I). Thus, 
we analyzed 231 nodules in 231 patients (164 females, 67 males; 
age range, 20 to 87 years; median age, 59 years; IQR, 48 to 70 
years). No patients were lost to follow-up.
Cytology 
The FNAC results for 85% of the nodules (196 of 231) were 
benign (TBSRTC category II) (Fig. 1) and were non-negative 
(TBSRTC category ≥III) for 15% (35 of 231) (Table 2). Among the 
35 non-negative nodules, 17 were malignant tumors (11 papillary 
carcinomas, 2 medullary carcinomas, 2 squamous carcinomas, and 2 
anaplastic carcinomas) (Fig. 2), 10 were adenomas (Fig. 3), one was 
an intraparenchymal parathyroid, and the remaining two nodules 
were a hyperplasia (TBSRTC category III) and a multinodular goiter 
(TBSRTC category IV). Five nodules, all classified as TBSRTC category 
III, underwent follow-up instead of being resected. Of these nodules, 
only one showed an increasing size during US follow-up; this patient 
underwent a second FNAC, which confirmed the primary diagnosis 
of follicular lesion of undetermined significance. The other four non-
Fig. 1. A benign nodule (the Bethesda System for Reporting 
Thyroid Cytopathology category II on fine-needle aspiration 
cytology) in the right thyroid lobe of a 43-year-old woman. A 
transverse ultrasonography shows an isoechoic and hyperechoic 
mixed solid-cystic nodule with well-defined margins (arrowheads). 
The total malignancy score of this nodule was 1 because of the 
mixed vascularization (not shown). 
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resected nodules remained stable over 2 years of US follow-up; one 
of them was aspirated again, with a benign cytological diagnosis. 
Bivariate Analysis, Multivariate Analysis, and TMS Accuracy
Among the 231 nodules that were examined, 108 (47%) had a 
TMS <3, 42 (18%) had a TMS of 3, and 81 (35%) had a TMS >3. 
Of the 198 definitively benign nodules (196 on cytology and 2 on 
histology), 107 (54%) had a TMS <3, 35 (18%) had a TMS of 3, and 
56 (28%) had a TMS >3. Among the 33 confirmed non-negative 
nodules, one (3%) had a TMS <3, seven (21%) had a TMS of 3, 
and 25 (76%) had a TMS >3; and none of the malignant nodules 
had a TMS <3. The median TMS was 2 (IQR, 1 to 4) for benign 
nodules and 4 (IQR, 4 to 6) for non-negative nodules, which was a 
statistically significant difference (P<0.001). 
The distribution of US features in non-negative and negative 
thyroid nodules and the results of the bivariate analysis are 
reported in detail in Table 3, and Table 4 presents the results 
of the multivariate analysis. In particular, in the multivariate 
analysis, hypoechogenicity, a solid structure, the presence of 
microcalcifications, and the number of nodules were independent 
predictors of the final diagnosis. The diagnostic accuracy of TMS 
was good, with an area under the ROC curve of 0.82 (Fig. 4). In 
contrast, the associations of the final diagnosis with nodule size 
and patient age were not statistically significant (P=0.715 and 
Table 2. Classification of the 231 thyroid nodules analyzed in this study according to the Bethesda System for Reporting Thyroid 
Cytopathology (TBSRTC) diagnostic categories compared to the total malignancy score (TMS) system and the final diagnosis
TBSRTC category
TMS  Final diagnosis
No. of patients (%)
<3 3 >3 Negative Positive
II 107 35 54 - - 196 (85)
III 1 3 7 1 10 11 (5)
IV 0 2 6 1 7 8 (3)
V 0 2 5 0 7 7 (3)
VI 0 0 9 0 9 9 (4)
Total 108 42 81 2 33 231 (100)
Fig. 2. A papillary carcinoma (confirmed by fine-needle aspiration 
cytology and surgery) in the left thyroid lobe of a 24-year-old 
woman. A transverse ultrasonography shows a single, hypoechoic, 
solid nodule with irregular margins (arrowheads), containing some 
fine areas of hyperechogenicity (arrows) without any comet-tail 
artifacts that grew by >20% in the preceding 6 months. The total 
malignancy score of this nodule was 8. 
Fig. 3. A follicular adenoma (the Bethesda System for Reporting 
Thyroid Cytopathology category III on fine-needle aspiration 
cytology) in the right thyroid lobe of a 76-year-old woman. A 
transverse ultrasonography shows a single solid nodule (shown 
in the square) with mixed vascularization on a power Doppler 
examination that grew by >20% in the preceding 6 months. The 
total malignancy score of this nodule was 5.
A US score for the management of thyroid nodules
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P=0.894, respectively). The shape of 44% of the nodules (102 of 
231) was recorded. A TTW shape was registered in 8% of them (8 
of 102), all of which had non-negative cytology (6 carcinomas and 
2 adenomas) (Fig. 5).
Discussion
Many studies have invest igated whether the ultrasound 
characteristics of thyroid nodules are useful indicators of histological 
malignancy. Overall, these investigations have identified a few 
ultrasound features that are significantly more frequent in malignant 
than in benign thyroid nodules; some authors have tried to define 
a set of characteristics that identify nodules at a higher risk of 
malignancy, while other studies have investigated the feasibility of 
applying the Breast Imaging Reporting and Data System (BI-RADS) 
concept to the US evaluation of thyroid nodules, calling it the Thyroid 
Imaging Reporting and Data System (TI-RADS) [5,6,10,13,16-
Table 3. Distribution of ultrasound features in the 231 thyroid nodules analyzed and results of the bivariate analysis
Nodule characteristic All nodules Non-negative nodules Negative nodules P-value (chi-square)
No. of nodules 0.051a)
    Single 84 (36) 17 (20) 67 (80)
    Multiple 147 (64) 16 (11) 131 (89)
Echogenicity <0.001b)
    Isoechoic or hyperechoic 148 (64) 8 (5) 140 (95)
    Hypoechoic 83 (36) 25 (30) 58 (70)
Structure <0.001b)
    Colloidal cyst or mixed 131 (57) 7 (5) 124 (95)
    Solid 100 (43) 26 (26) 74 (74)
Halo 0.795
    Absent or continuous 206 (89) 29 (14) 177 (86)
    Discontinuous 25 (11) 4 (16) 21 (84)
Margins <0.001b)
    Regular 206 (89) 23 (11) 183 (89)
    Irregular 25 (11) 10 (40) 15 (60)
Vascularity 0.018b)
    Absent or peripheral 92 (40) 7 (8) 85 (92)
    Intranodular or mixed 139 (60) 26 (19) 113 (81)
Calcifications 0.005b)
    Absent or macrocalcifications 198 (86) 23 (12) 175 (88)
    Microcalcifications 33 (14) 10 (30) 23 (70)
Growthc) 0.626
    Negative 189 (82) 26 (14) 163 (86)
    Positive 42 (18) 7 (17) 35 (83)
Taller than wided)
    No 94 (92) 18 (19) 76 (81)
    Yes 8 (8) 8 (100) 0 (
Values are presented as number (%). 
a)Borderline P-value. b)Statistically significant P-values. c)≥20% in 6 months. d)Calculated for 102 or 231 nodules (see text for details).
Table 4. Results of multivariate analysis
Nodule characteristic Odds ratio P-value
No. of nodules 2.480 0.046a)
Hypoechogenicity 5.560 <0.001a)
Solid structure 3.270 0.018a)
Irregular margins 2.890 0.053
Intranodular or mixed vascularity 2.720 0.052
Microcalcifications 3.090 0.035a)
a)Independent predictors of the final diagnosis.
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19]. The goal was to group thyroid lesions in different categories 
with percentages of malignancy similar to those of the BI-RADS 
categories. However, no standard TI-RADS classification system is 
yet widely accepted and used in routine clinical practice [13,14,20]. 
It is well known that no single US feature allows the differentiation 
of malignant and benign thyroid lesions. However, the presence of 
multiple suspicious features in a nodular lesion is closely correlated 
with the nodule’s risk of malignancy, suggesting that the global 
appearance of each nodule, including all its features, should be 
considered for diagnosis [6,21,22]. 
The aim of our study was to validate the TMS in a large series 
of consecutive patients, in order to optimize the diagnostic and 
therapeutic management of thyroid nodular lesions. The TMS, which 
is based on indications already described in the literature that have 
been adopted, is simple to use and to interpret [6,9,13,15,17,23]. It 
constitutes a basis to stratify patients into groups with different risks 
of malignancy. Adamczewski and Lewinski [21] recently described 
a similar attempt, evaluating 200 lesions in 111 patients, with 
encouraging results that were helpful in making proper diagnostic 
and therapeutic decisions. Those authors proposed a scoring system 
Fig. 5. A follicular adenoma (confirmed at surgery, follicular proliferation on fine-needle aspiration cytology) in the right thyroid lobe of 
a 47-year-old woman. 
A, B. A transverse ultrasonography shows a single, isoechoic, thyroid nodule with regular margins, a taller-than-wide shape (A, 
anteroposterior diameter, 23 mm; latero-lateral diameter, 19 mm and B, a peri-intranodular Doppler signal). The total malignancy score of 
this nodule was 4. 
A B
Fig. 4. Receiver operating characteristic (ROC) analysis showing 
that the total malignancy score had good diagnostic accuracy 
(area under the ROC curve, 0.82).
1-Specificity
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based on US features that grouped patients into three prognostic 
categories [21]. They found microcalcifications (odds ratio [OR], 
24.67), a TTW shape (OR, 301), increased intranodular vascularity 
(OR, 20.44), and hypoechogenicity (OR, 18.61) to be features 
suggestive of malignancy. Other authors have stated that the 
presence of at least two US features suspicious for malignancy may 
be the best criterion for recommending FNAC [22].
The reliability of our scoring system was good, with a significant 
difference between the median TMS of benign and non-negative 
nodules (P<0.001). Approximately 75% of the non-negative 
nodules had a score >3 and none of the malignant ones had a 
score <3. Our experience confirmed that we could assess the risk of 
malignancy in a graduated manner according to the TMS category, 
with no risk or negligible risk for a TMS <3, low risk for a TMS of 
3, and medium or high risk for higher TMS values. An innovation in 
our scoring system compared to other studies was that we not only 
included the US features of the nodule, but also accounted for the 
fact that a single nodule, regardless of its appearance, in a normal 
gland could be more dangerous than a nodule in a multi-nodular 
gland [10,22,24,25]. This was confirmed by the results of the 
multivariate analysis, in which the presence of a single nodule was 
an independent predictor of non-negativity. Our results confirmed 
the previously established reliability of certain US characteristics as 
predictors of malignancy, such as hypoechogenicity, a solid structure, 
irregular margins, and microcalcifications [5,7,9,12]. Moreover, our 
results showed that a TTW shape was an exclusive characteristic of 
non-negative nodules, as it was not detected in any benign nodules. 
This is in agreement with a recent meta-analysis that showed a TTW 
shape to be the strongest predictor of malignancy, despite a quite 
low sensitivity [1].
This study has several limitations. First, selection bias could have 
been present in the choice of patients, but only to an extent that 
reflects clinical practice. Second, all nodules with negative cytology 
results were considered to be definitively benign, and no further 
procedures or follow-up was performed, but this also reflects clinical 
practice. Moreover, we do not think it would be ethically sound to 
force patients with nodules highly likely to be benign to undergo 
surgery solely to obtain histological proof of the benignity of the 
nodule. Thus, false-negatives could have been present among the 
cytology results, potentially affecting our conclusions. Third, the 
results for the TTW shape are limited to approximately half of the 
population, as we began to consider this feature later, based on 
updated research findings [1]. Finally, interobserver variability in 
the interpretations of US images among the radiologists was not 
evaluated; however, we think that all properly-trained sonographers 
can easily recognize the features considered in the TMS. 
In conclusion, although the proposed TMS still requires scientific 
validation in a larger cohort of patients, we are confident that 
it will become useful for all sonographers dealing with nodular 
thyroid disease, and its simplicity should ensure its wider diffusion. 
According to our results, we suggest limiting FNAC to nodules with 
a TMS ≥3. In our population, this would have limited the number 
of interventional procedures to 53% (123 of 231) of the nodules, 
without missing any carcinomas. In the presence of economic and/
or organizational reasons to strongly restrict the number of FNACs, 
a good compromise between the risk of missing carcinomas and 
the need to avoid unnecessary procedures would probably be 
represented by restricting FNAC to nodules with a TMS ≥4, with 
follow-up required for nodules with a TMS of 3. In our population, 
this would have limited the number of interventional procedures to 
35% (81 of 231), missing 24% of the non-negative nodules (8 of 
33). We therefore advocate this scoring system as a simple-to-use, 
reliable, and easily reproducible tool.
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